The Baby Powder in Your Cabinet Just Cost a Company $5.5 Billion

Think about the women in your life — a daughter, a mother, a sister who still keeps that familiar white bottle tucked in the medicine cabinet out of habit. Johnson & Johnson has now offered $5.5 billion to settle lawsuits claiming its talcum powder caused ovarian cancer in women who used it for years, sometimes decades. The company announced the proposed settlement this week, aiming to resolve roughly 76,000 remaining claims filed across the country.

It's a staggering number. But behind it are individual women who trusted a product marketed for babies and used it well into adulthood, never imagining it could be linked to a cancer diagnosis.

The Company Still Says No Link Exists

J&J hasn't admitted fault. The company maintains the science doesn't support a connection between its talc products and cancer, and points out it has won most cases that actually went to trial. Erik Haas, the company's vice president of litigation, said the settlement lets J&J move forward rather than concede wrongdoing.

(Photo by Justin Sullivan/Getty Images)

Plaintiffs' attorneys tell a different story. Lead counsel Chris Seeger called the deal overdue relief after more than a decade of litigation and three failed bankruptcy attempts by the company. Talc-based Johnson's Baby Powder came off store shelves in the U.S. and Canada in 2020.

Not a Done Deal Yet

The settlement isn't finalized. J&J requires at least 95% of remaining claimants to sign on, a threshold that could still fall apart. For families across the Wenatchee Valley who grew up with that familiar bottle on the bathroom shelf, the outcome carries real weight — not just as a legal headline, but as a question about a product many trusted without a second thought.

This is not the first time Johnson & Johnson has been sued for its baby powder